<DOC>
	<DOCNO>NCT02070133</DOCNO>
	<brief_summary>To evaluate patient stable Chronic Obstructive Pulmonary Disease ( COPD ) efficacy statin ( simvastatin ) : ( 1 ) endothelial function ; ( 2 ) systemic inflammation ; ( 3 ) BODE ( B : body mass , O : bronchial obstruction , D : dyspnea , E : exercise tolerance ) index ; ( 4 ) Uric acid ; , ( 5 ) vascular growth factor . Design : 12 week randomize ( 1:1 ) , double-blind , placebo control study . Population : 18 male stable COPD 40-80 year age , exsmokers , Forced expiratory volume one second ( FEV1 ) 30 80 % predict post-bronchodilation .</brief_summary>
	<brief_title>Efficacy Simvastatin Treatment COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Stable COPD 4080 year age , exsmokers , FEV1 low 80 % predicted postbronchodilation . Severe comorbidity ( advancedstage cancer , tuberculosis affect third total lung parenchyma , pneumonectomy , pneumoconiosis , leave cardiac failure previously report , know cardiopathy ventricular dysfunction ( ejection fraction &lt; 45 % ) cardiovascular disease , Diabetes Mellitus treat insulin , Hypercholesterolemia , Chronic inflammatory disease ( asthma , rheumatoid arthritis , lung fibrosis , autoimmune disease ) , Treatment systemic steroid , non steroidal antiinflammatory drug stain within 3 month prior inclusion .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Chronic Bronchitis</keyword>
	<keyword>Statins</keyword>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Systemic inflammation</keyword>
	<keyword>BODE index</keyword>
	<keyword>Uric acid</keyword>
	<keyword>Vascular growth factor</keyword>
</DOC>